C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2004
10/14/2004	US20040202655 antibody or antigen binding portion thereof that specifically binds to IGF-IR, administered for tumor or cancer treatment; also a nucleic acid molecule that comprises sequence that encodes the antibody or fragment
10/14/2004	US20040202653 Peptide-based passive immunization therapy for treatment of atherosclerosis
10/14/2004	US20040202651 Uses of anti-insulin-like growth factor 1 receptor antibodies
10/14/2004	US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies
10/14/2004	US20040202648 Vaccines
10/14/2004	US20040202647 T cell line specific for a nitrotyrosine-containing compound; antibody specific for a self-antigen comprising a tyrosine to nitrotyrosine conversion; prevention and treatment of autoimmune diseases, infectious diseases and cancer through the recognition of compounds containing nitrated tyrosine residues
10/14/2004	US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004	DE10314412A1 Genetische Immunisierung mit multiplen Expressionskonstrukten zur Herstellung von monoklonalen Antikörpern Genetic immunization with multiple expression constructs for the production of monoclonal antibodies
10/14/2004	DE10297379T5 Kombinationstherapie zur Krankheitsbehandlung Combination therapy for the treatment of disease
10/14/2004	CA2560972A1 Proteomic analysis of biological fluids
10/14/2004	CA2521106A1 Intracellular complexes as biomarkers
10/14/2004	CA2520936A1 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
10/14/2004	CA2520868A1 Staphylococcus epidermidis antigens
10/14/2004	CA2520830A1 Method for inducing differentiation and/or proliferating regulatory t cells using anti-cd52 antibodies and pharmaceutical composition therefor
10/14/2004	CA2520820A1 Therapeutic products with enhanced ability to immunomodulate cell functions
10/14/2004	CA2520671A1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
10/14/2004	CA2520389A1 Method and compositions for conversion of antibody activity
10/14/2004	CA2520382A1 Lupus antibodies for passive immunotherapy of hiv/aids
10/14/2004	CA2520381A1 Proteolytic and covalent antibodies
10/13/2004	EP1467212A1 Process for differential diagnosis of Alzheimer's denmentia and device therefor
10/13/2004	EP1466977A1 Methods and compositions for inhibiting neoplastic cell growth
10/13/2004	EP1466925A1 Antibodies against fibroblast growth factor 23
10/13/2004	EP1466924A1 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
10/13/2004	EP1466624A1 Drug for regenerating tissue and vessel and method therefor
10/13/2004	EP1466623A1 Remedies for arthritis
10/13/2004	EP1466622A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia
10/13/2004	EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment
10/13/2004	EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004	EP1465928A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
10/13/2004	EP1465927A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
10/13/2004	EP1465926A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
10/13/2004	EP1465925A2 Antibodies that immunospecifically bind to trail receptors
10/13/2004	EP1465923A1 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465922A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465921A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465919A2 Insect g protein-coupled receptor genes and uses thereof
10/13/2004	EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004	EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004	EP1465661A1 Cancer treatment
10/13/2004	EP1465660A2 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor
10/13/2004	EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004	EP1465489A2 Methods of expressing lim mineralization protein in non-osseous cells
10/13/2004	EP1286682A4 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
10/13/2004	EP1257584B1 Humanized antibodies that sequester amyloid beta peptide
10/13/2004	EP1154786B1 Compositions for altering mucus secretion
10/13/2004	EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction
10/13/2004	EP0935757B1 Assessment of cervical cells
10/13/2004	EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same
10/13/2004	EP0853647B1 Fluorinated xanthene derivatives
10/13/2004	EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases
10/13/2004	EP0817847B1 Il-17 receptor
10/13/2004	EP0688361B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/13/2004	EP0637933B1 Method for treating organs and tissues
10/13/2004	EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
10/13/2004	CN1537167A Von willebrand factor (VWF)-cleaving enzyme
10/13/2004	CN1537166A New elongase gene and production of Delta 9-polyunsaturated fatty acids
10/13/2004	CN1537017A Remedie for inflammatory bowel diseases
10/13/2004	CN1537015A Stable liquid formulations of antibodies
10/13/2004	CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
10/13/2004	CN1535985A Genetically-engineered single chain antibody scFv 25 for resisting liver cancen
10/13/2004	CN1535728A Drug composition for curing disease produced from IL-6
10/13/2004	CN1170934C Proteins derived from white spot syndrome virus and uses thereof
10/13/2004	CN1170933C Motilin homologs
10/13/2004	CN1170931C Vasculogenesis correlation molecule
10/13/2004	CN1170929C Human protein able to suppress growth of cancer cells and its coding sequence
10/13/2004	CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004	CN1170843C Novel huamn protein with function of promoting growth of cancer cell and its code sequence
10/13/2004	CN1170594C 弯曲菌疫苗 Campylobacter vaccine
10/13/2004	CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors
10/12/2004	US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004	US6803449 Polypeptide for use in the diagnosis and treatment viral diseases
10/12/2004	US6803232 Neuropeptide y (npy) receptor (designated npy- y7) used to express the receptor in cells which can then be used for drug screening
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803209 Nutrient for use in the propagation of microorganism and the generation of heterologous proteins
10/12/2004	US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same
10/12/2004	US6803189 Methods for the detection of cervical cancer
10/12/2004	US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/12/2004	US6803041 Chemically inactivated ehv-1 kya virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer.
10/12/2004	US6803040 Derivatives of tricyclic antidepressants and protein and polypeptide tricyclic antidepressant derivative conjugates and labels
10/12/2004	US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/12/2004	US6803035 Administering an egg product to the animal suffering from the diarrhea, and the egg product is obtained from a hyperimmunized avian with an immunogenic or genetic vaccine
10/12/2004	CA2387401C Compositions, methods and systems for the production of enediynes
10/10/2004	CA2425086A1 Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies
10/07/2004	WO2004086048A1 Diagnosis of advanced cancer
10/07/2004	WO2004085648A2 Nogo receptor binding protein
10/07/2004	WO2004085479A2 Treatment of viral infections
10/07/2004	WO2004085478A2 Improved fc fusion proteins
10/07/2004	WO2004085477A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
10/07/2004	WO2004085476A2 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
10/07/2004	WO2004085475A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation
10/07/2004	WO2004085474A2 Method of producing an antibody to epidermal growth factor receptor
10/07/2004	WO2004085468A2 Human p53 splice variant displaying differential transcriptional activity
10/07/2004	WO2004085455A1 A diagnostic assay for the human virus causing severe acute respiratory syndrome (sars)
10/07/2004	WO2004084945A1 Eating controllers
10/07/2004	WO2004084943A1 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
10/07/2004	WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
10/07/2004	WO2004084841A2 Novel anti-feline albumin antibodies and methods of detecting early renal disease
10/07/2004	WO2004084836A2 Methods for treating taxol-induced gut disorder
10/07/2004	WO2004084823A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/07/2004	WO2004084821A2 Hemipteran glutamate decarboxylase

1 ... 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 ... 1494